🇺🇸 FDA
Patent

US 10844376

Structurally-enhanced miRNA inhibitor S-TuD

granted A61KA61K31/712A61K31/713

Quick answer

US patent 10844376 (Structurally-enhanced miRNA inhibitor S-TuD) held by GeneDesign, Inc. expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GeneDesign, Inc.
Grant date
Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/712, A61K31/713, A61K48/00